David A. Costa, Ph.D.
|2005||University of South Florida, Tampa, FL, United States|
Area:Alzheimer's Disease, Down Syndrome
Mean distance: 15087
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Nilsson LN, Gografe S, Costa DA, et al. (2012) USE OF FUSED CIRCULATIONS TO INVESTIGATE THE ROLE OF APOLIPOPROTEIN E AS AMYLOID CATALYST AND PERIPHERAL SINK IN ALZHEIMER'S DISEASE. Technology and Innovation. 14: 199-208|
|Costa DA, Cracchiolo JR, Bachstetter AD, et al. (2007) Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiology of Aging. 28: 831-44|
|Costa DA, Nilsson LN, Bales KR, et al. (2004) Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Abeta deposition, in an AbetaPP/PS double transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 6: 509-14|
|Nilsson LN, Arendash GW, Leighty RE, et al. (2004) Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiology of Aging. 25: 1153-67|
|Arendash GW, Garcia MF, Costa DA, et al. (2004) Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport. 15: 1751-4|
|Leighty RE, Nilsson LN, Potter H, et al. (2004) Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Behavioural Brain Research. 153: 107-21|